{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:15:57Z","timestamp":1793272557095,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["203312"],"award-info":[{"award-number":["203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ecl.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:02:51Z","timestamp":1761087771000},"page":"549-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas"],"prefix":"10.1016","volume":"54","author":[{"given":"Kevin A.","family":"Huynh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waiel A.","family":"Bashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ecl.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.ecl.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11154-025-09944-x","article-title":"Pituitary adenomas: biology, nomenclature and clinical classification","volume":"26","author":"Ho","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ecl.2025.08.001_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-025-01134-8","article-title":"Pituitary incidentaloma: a Pituitary Society international consensus guideline statement","author":"Fleseriu","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ecl.2020.06.002","article-title":"Advances in the imaging of pituitary tumors","volume":"49","author":"MacFarlane","year":"2020","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"10.1016\/j.ecl.2025.08.001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.05.002","article-title":"Modern imaging of pituitary adenomas","volume":"33","author":"Bashari","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.ecl.2025.08.001_bib6","series-title":"The pituitary","first-page":"677","article-title":"Chapter 23 - pituitary imaging","author":"Bashari","year":"2022"},{"issue":"3","key":"10.1016\/j.ecl.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3174\/ajnr.A7789","article-title":"MRI for cushing disease: a systematic review","volume":"44","author":"Castle-Kirszbaum","year":"2023","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ecl.2025.08.001_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-025-09978-1","article-title":"Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic review","author":"Chiloiro","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"57s","DOI":"10.2967\/jnumed.120.251546","article-title":"Using molecular imaging to enhance decision making in the management of pituitary adenomas","volume":"62","author":"Bashari","year":"2021","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.ecl.2025.08.001_bib10","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220158","article-title":"Seeing more with less: clinical benefits of photon-counting detector CT","volume":"43","author":"Nehra","year":"2023","journal-title":"Radiographics"},{"key":"10.1016\/j.ecl.2025.08.001_bib11","article-title":"Neuroimaging applications of photon-counting CT","author":"Dogra","year":"2025","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.ecl.2025.08.001_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/bjr\/tqaf082","article-title":"Neuro applications of photon-counting CT","author":"Hiwatashi","year":"2025","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ecl.2025.08.001_bib13","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A8893","article-title":"Pituitary photon counting detector CT for cushing disease: pre-operative lesion localization, intraoperative findings, and post-operative outcomes","author":"Mark","year":"2025","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1148\/radiol.2021204740","article-title":"Diffusion MRI in peripheral nerves: optimized b values and the role of non-Gaussian diffusion","volume":"302","author":"Foesleitner","year":"2022","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ecl.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00234-024-03467-z","article-title":"Role of diffusion-weighted imaging in the diagnosis of pituitary region tumors","volume":"67","author":"Korbecki","year":"2025","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.ecl.2025.08.001_bib16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jmri.29531","article-title":"The diagnostic value of conventional MRI combined with diffusion-weighted imaging in microprolactinomas","volume":"61","author":"Wang","year":"2025","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.ecl.2025.08.001_bib17","first-page":"329","article-title":"Three-Tesla imaging of the pituitary and parasellar region: T1-weighted 3-dimensional fast spin echo cube outperforms conventional 2-dimensional magnetic resonance imaging","volume":"39","author":"Lien","year":"2015","journal-title":"J Comput Assist Tomogr"},{"issue":"12","key":"10.1016\/j.ecl.2025.08.001_bib18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00234-014-1432-1","article-title":"Assessment of pituitary micro-lesions using 3D sampling perfection with application-optimized contrasts using different flip-angle evolutions","volume":"56","author":"Wang","year":"2014","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.ecl.2025.08.001_bib19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3171\/2017.3.JNS163122","article-title":"Comparison of MRI techniques for detecting microadenomas in Cushing\u2019s disease","volume":"128","author":"Grober","year":"2018","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.ecl.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1507\/endocrj.EJ18-0458","article-title":"Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing\u2019s disease","volume":"66","author":"Fukuhara","year":"2019","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.ecl.2025.08.001_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/cen.12069","article-title":"Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas","volume":"78","author":"Kasaliwal","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejrad.2009.12.036","article-title":"Three-dimensional gradient echo versus spin echo sequence in contrast-enhanced imaging of the pituitary gland at 3T","volume":"79","author":"Kakite","year":"2011","journal-title":"Eur J Radiol"},{"issue":"9","key":"10.1016\/j.ecl.2025.08.001_bib23","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1007\/s00330-023-09585-1","article-title":"High-resolution contrast-enhanced MRI with three-dimensional fast spin echo improved the diagnostic performance for identifying pituitary microadenomas in Cushing\u2019s syndrome","volume":"33","author":"Liu","year":"2023","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12880-025-01786-y","article-title":"Improved noninvasive diagnostic evaluations in treatment-na\u00efve adrenocorticotropic hormone (ACTH)-dependent Cushing\u2019s syndrome","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.ecl.2025.08.001_bib25","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1016\/j.wneu.2024.03.066","article-title":"MRI 3D SPACE T2WI for pituitary adenoma cavernous sinus invasion diagnosis","volume":"185","author":"Chen","year":"2024","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ecl.2025.08.001_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2023.100500","article-title":"Utility of contrast-enhanced 3D STIR FLAIR imaging for evaluating pituitary adenomas at 3 Tesla","volume":"11","author":"Osawa","year":"2023","journal-title":"Eur J Radiol Open"},{"issue":"6","key":"10.1016\/j.ecl.2025.08.001_bib27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3174\/ajnr.A8596","article-title":"Contrast-enhanced CISS\/FIESTA imaging for increased conspicuity of pituitary microadenomas in cushing disease","volume":"46","author":"Mark","year":"2025","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ecl.2025.08.001_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neuroimage.2016.11.031","article-title":"Key clinical benefits of neuroimaging at 7T","volume":"168","author":"Trattnig","year":"2018","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00330-015-3809-x","article-title":"High resolution pituitary gland MRI at 7.0 tesla: a clinical evaluation in Cushing\u2019s disease","volume":"26","author":"de Rotte","year":"2016","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.ecl.2025.08.001_bib30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00234-020-02431-x","article-title":"Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas","volume":"62","author":"Patel","year":"2020","journal-title":"Neuroradiology"},{"issue":"8","key":"10.1016\/j.ecl.2025.08.001_bib31","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00330-014-3230-x","article-title":"Feasibility of high-resolution pituitary MRI at 7.0 tesla","volume":"24","author":"de Rotte","year":"2014","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.ecl.2025.08.001_bib32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3174\/ajnr.A8209","article-title":"7T MRI for cushing disease: a single-institution experience and literature review","volume":"45","author":"Mark","year":"2024","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"10.1016\/j.ecl.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/RLI.0000000000000872","article-title":"Ultra-high-field 7 T magnetic resonance imaging including dynamic and static contrast-enhanced T1-weighted imaging improves detection of secreting pituitary microadenomas","volume":"57","author":"Eisenhut","year":"2022","journal-title":"Investig Radiol"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/life13010049","article-title":"Improved detection of cavernous sinus invasion of pituitary macroadenomas with ultra-high-field 7 T MRI","volume":"13","author":"Eisenhut","year":"2023","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.ecl.2025.08.001_bib35","doi-asserted-by":"crossref","DOI":"10.3171\/2016.1.FOCUS15515","article-title":"The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite","volume":"40","author":"Zaidi","year":"2016","journal-title":"Neurosurg Focus"},{"issue":"4","key":"10.1016\/j.ecl.2025.08.001_bib36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1080\/02688697.2021.1981237","article-title":"3 Tesla intra-operative MRI as an adjunct to endoscopic pituitary surgery: an early assessment of clinical utility","volume":"38","author":"Hannan","year":"2024","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.ecl.2025.08.001_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.wneu.2023.04.126","article-title":"Intraoperative ultrasonography in pituitary surgery revisited: an institutional experience and systematic review on applications and considerations","volume":"176","author":"Mosallami Aghili","year":"2023","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.ecl.2025.08.001_bib38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00259-024-06947-9","article-title":"Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]","volume":"52","author":"Schmidt","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.ecl.2025.08.001_bib39","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.30.5.056002","article-title":"First-in-human pilot study of snapshot multispectral endoscopy for delineation of pituitary adenoma","volume":"30","author":"Waterhouse","year":"2025","journal-title":"J Biomed Opt"},{"issue":"4","key":"10.1016\/j.ecl.2025.08.001_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.semnuclmed.2023.02.005","article-title":"Molecular imaging of pituitary tumors","volume":"53","author":"Gillett","year":"2023","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10.1016\/j.ecl.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ejendo\/lvae028","article-title":"Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly","volume":"190","author":"Haberbosch","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ecl.2025.08.001_bib42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11102-022-01230-2","article-title":"Implementation of functional imaging using (11)C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery","volume":"25","author":"Bakker","year":"2022","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.ecl.2025.08.001_bib43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11102-022-01229-9","article-title":"(11)C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy","volume":"25","author":"Bashari","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2025.08.001_bib44","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaf047","article-title":"Diagnostic value of 11C-Methionine PET-CT imaging in persistent or recurrent Cushing\u2019s disease after surgery","author":"Furnica","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3171\/2023.5.JNS23179","article-title":"Clinical decision-making based on 11C-methionine PET in recurrent Cushing\u2019s disease with equivocal MRI findings","volume":"139","author":"Ishida","year":"2023","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11307-019-01337-2","article-title":"The impact of positron range on PET resolution, evaluated with phantoms and PHITS Monte Carlo simulations for conventional and non-conventional radionuclides","volume":"22","author":"Carter","year":"2020","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1016\/j.ecl.2025.08.001_bib47","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2967\/jnumed.123.266853","article-title":"[(18)F]FET PET\/MRI: an accurate technique for detection of small functional pituitary tumors","volume":"65","author":"Pruis","year":"2024","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.ecl.2025.08.001_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cen.15079","article-title":"(18)F-fluoro-ethyl-tyrosine PET co-registered with MRI in patients with persisting acromegaly","volume":"101","author":"Bakker","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ecl.2025.08.001_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s11102-024-01430-y","article-title":"Clinical use of [(18)F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants","volume":"27","author":"van Trigt","year":"2024","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.ecl.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s11102-021-01160-5","article-title":"Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET\/MRI","volume":"24","author":"Berkmann","year":"2021","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/RLU.0000000000000272","article-title":"Dual-isotope 99mTc-MIBI\/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT\/CT and pinhole planar scan","volume":"39","author":"Hassler","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40644-023-00600-8","article-title":"Dexamethasone suppression for (18)F-FDG PET\/CT to localize ACTH-secreting pituitary tumors","volume":"23","author":"Kim","year":"2023","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13550-022-00899-7","article-title":"Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction","volume":"12","author":"Gillett","year":"2022","journal-title":"EJNMMI Res"},{"issue":"12","key":"10.1016\/j.ecl.2025.08.001_bib54","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S2213-8587(16)30311-4","article-title":"Localisation of an occult thyrotropinoma with 11C-methionine PET-CT before and after somatostatin analogue therapy","volume":"4","author":"Koulouri","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2967\/jnumed.115.163865","article-title":"Safety and efficacy of 68Ga-DOTATATE PET\/CT for diagnosis, staging, and treatment management of neuroendocrine tumors","volume":"57","author":"Deppen","year":"2016","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.ecl.2025.08.001_bib56","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s40618-021-01523-6","article-title":"Evaluation of (68)Ga-DOTATATE uptake at the pituitary region and the biochemical response to somatostatin analogs in acromegaly","volume":"44","author":"Daniel","year":"2021","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41824-020-0073-3","article-title":"(68)Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas","volume":"4","author":"Boertien","year":"2020","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.ecl.2025.08.001_bib58","article-title":"Lanreotide versus placebo for tumour reduction in patients with a (68)Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): a randomised, multicentre, phase 3 trial with blinded outcome assessment","volume":"42","author":"Boertien","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41824-021-00104-3","article-title":"The value of [68Ga]Ga-DOTA-TATE PET\/CT in diagnosis and management of suspected pituitary tumors","volume":"5","author":"Novruzov","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.ecl.2025.08.001_bib60","doi-asserted-by":"crossref","DOI":"10.3803\/EnM.2024.2249","article-title":"68Ga-DOTATOC PET\/CT in the localization of pituitary tumors in cushing\u2019s disease","author":"Kim","year":"2025","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"8","key":"10.1016\/j.ecl.2025.08.001_bib61","first-page":"642","article-title":"Development of (68)Ga DOTA-CRH for PET\/CT imaging of ACTH-dependent Cushing\u2019s disease: initial study","volume":"36","author":"Shukla","year":"2021","journal-title":"Cancer Biother Radiopharm"},{"issue":"4","key":"10.1016\/j.ecl.2025.08.001_bib62","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/clinem\/dgaa755","article-title":"Molecular imaging targeting corticotropin-releasing hormone receptor for corticotropinoma: a changing paradigm","volume":"106","author":"Walia","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.08.001_bib63","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07304-0","article-title":"A novel molecular imaging technique using [68Ga]Ga-mDesmo PET-CT for localizing tumors in Cushing\u2019s disease","author":"Walia","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"3","key":"10.1016\/j.ecl.2025.08.001_bib64","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233469","article-title":"Diagnostic accuracy and value of CXCR4-targeted PET\/MRI using (68)Ga-pentixafor for tumor localization in cushing disease","volume":"313","author":"Wu","year":"2024","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.ecl.2025.08.001_bib65","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.acra.2018.09.015","article-title":"Utility of 13N-ammonia PET\/CT to detect pituitary tissue in patients with pituitary adenomas","volume":"26","author":"Wang","year":"2019","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib66","first-page":"44","article-title":"Dynamic 13N-ammonia PET: a new imaging method to diagnose hypopituitarism","volume":"46","author":"Xiangsong","year":"2005","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.ecl.2025.08.001_bib67","first-page":"671","article-title":"Evaluation of myocardial metabolism, with N-13- and C-11-labeled amino acids and positron computed tomography","volume":"23","author":"Henze","year":"1982","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.ecl.2025.08.001_bib68","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.CIR.63.6.1259","article-title":"N-13 ammonia as an indicator of myocardial blood flow","volume":"63","author":"Schelbert","year":"1981","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib69","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/s12885-021-08574-1","article-title":"The combination of (13)N-ammonia and (11)C-methionine in differentiation of residual\/recurrent pituitary adenoma from the pituitary gland remnant after trans-sphenoidal Adenomectomy","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2025.08.001_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12902-024-01543-2","article-title":"Clinical application of combination [(11)C]C-methionine and [(13)N]N-ammonia PET\/CT in recurrent functional pituitary adenomas with negative MRI or [(18)F]F-FDG PET\/CT","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Endocr Disord"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:19:01Z","timestamp":1772932741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852925000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0889852925000787"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2025.08.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}